A real-life experience using panitumumab in chemo-refractory metastatic colorectal cancer patients: a retrospective analysis at the Jewish General Hospital, 2009-2012. | Curr Oncol;20(2): e107-12, 2013 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

A real-life experience using panitumumab in chemo-refractory metastatic colorectal cancer patients: a retrospective analysis at the Jewish General Hospital, 2009-2012.

Mamo, A; Nogueira, M Cardoso; Batist, G; Palumbo, M; Panasci, L; Ferrario, C; Chaudhury, P; Metrakos, P; Kavan, P.

Affiliation

Mamo A; Department of Oncology, McGill University, and the Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC.

Curr Oncol ; 20(2): e107-12, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23559877

Key words

Metastatic colorectal cancer; overall survival; panitumumab; progression-free survival; safety

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Curr Oncol Year: 2013 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Curr Oncol Year: 2013 Document type: Article Country of publication: